Sponsor pipeline

Umoja Biopharma clinical trial pipeline

Get alerts when Umoja Biopharma's trials change

3 active trials 2 recruiting 6 disease areas 1 changes in 30 days

Data updated daily from ClinicalTrials.gov, last refresh 2026-10-11

What changed in the last 30 days

1 trial changed in the last 30 days: 0 stopped, 1 with a notable change, 0 with minor changes only.

  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.

Active trials by phase

Phase 1
2
Phase 1/2
1

Active trials

NCT IDTitleConditionStatusUpdated
Phase 1/2
NCT07735533 A Phase 1/2 Study of UB-VV400 With Rapamycin in Relapsed/Refractory B-cell Malignancies Lymphoma, B Cell Recruiting 2026-10-09
Phase 1
NCT06528301 A Phase 1 Study of UB-VV111 With and Without Rapamycin in Relapsed/Refractory CD19+… Lymphoma, B-Cell Recruiting 2026-10-07
NCT07735546 A Phase 1 Study of UB-VV500 With Rapamycin in Relapsed/Refractory Multiple Myeloma Multiple Myeloma in Relapse Not Yet Recruiting 2026-08-17

Disease areas by active trials

DLBCL (2) · Non-Hodgkin Lymphoma (2) · Chronic Lymphocytic Leukemia (CLL) (1) · Follicular Lymphoma (1) · Leukemia (1) · Multiple Myeloma (1)

Get alerts when Umoja Biopharma's trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.
Start monitoring free